Sam Misir, PharmD, MBA, currently serves as Director at Regeneron since December 2022. Previously, Sam held the position of Executive Director at Zentalis Pharmaceuticals from August 2021 to September 2022 and served as Sr. Medical Director at UroGen Pharma from May 2020 to August 2021. Prior roles include Head of Medical Strategy and Operations in Oncology at Ferring Pharmaceuticals, Sr. Medical Director - Oncology and Global Medical Lead at Eisai US, and Director of Medical Affairs in Oncology at Daiichi Sankyo. Sam began a career in medical science at P&G Pharmaceuticals as Sr. Medical Science Liaison. Sam holds an MBA from Indiana University - Kelley School of Business, a B.S. in Pharmacy from Long Island University, and a Doctor of Pharmacy from Nova Southeastern University.
This person is not in any teams
This person is not in any offices